AGING - High-Impact Journal on Aging Research
The ongoing revolution in aging research calls for a High-Impact Research, Open-Access Journal.
AGING primarily publishes papers of outstanding significance, exceptional novelty, and ground-breaking discoveries in all disciplines from yeast to humans and from evolution to medicine. AGING covers (in addition to traditional topics on aging) many other topics including cellular and molecular biology (regulation of translation, cell growth, death and autophagy, mitochondria, DNA damage and repair, microRNAs, stem cells), human age-related diseases, pathology in model organisms, cancer and first of all signal transduction pathways (p53, sirtuins, PI-3K/AKT/mTOR and so on) and approaches to modulate these signaling pathways. AGING welcomes scientists in all disciplines, not only those in traditional gerontology.
Revolutionary publishing allows us to publish overnight with the highest exposure.
AGING is abbreviated by indexes: by PubMed - Aging (Albany NY); by ISI/Thomson - Aging-US; by Scopus - Aging.
August 6, 2014: According to Scopus/SJR/Journal Rank, Aging ranks first (out of 33 journals) in the "Aging category" on cites per document . Cites per doc (2y) for Aging=7.66: equivalent to 7.66 impact factor.
July 23, 2014: Elsevier has released the latest Journal Metrics based on Scopus data: SCImago Journal Rank (SJR). For Aging, SJR 2013 increased by 49% compared with the last year SJR 2012.
Elizabeth Blackburn, a member of the Editorial Board of AGING, won the Nobel Prize in Physiology or Medicine 2009. Elizabeth Blackburn co-authored a paper published in the first (inaugural) issue of AGING.